Bmab3000
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bmab3000, covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteers [Phase 1]